| 15 Dec 2009 - Chemotargets to participate in eTOX, an EU-funded IMI project |
| Chemotargets will be participating in the eTOX project that aims at the in silico prediction of in vivo toxicities associated with drugs and drug candidates. The eTOX project was successfully selected within its subject category in the first call of the Innovative Medicines Initiative and it will be undertaken by a consortium composed of 11 European pharmaceutical companies and 12 public partners (including both academic institutions and small and medium enterprises). The project will officially kick-off on January 2010 and will last for five years. |